Corrigendum to ‘Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity’ [Redox Biol. 14 (2018) 237–249]
Main Authors: | Xiaoqing Zheng, Weiwei Ma, Ruoxuan Sun, Hanwei Yin, Fei Lin, Yuxi Liu, Wei Xu, Huihui Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | Redox Biology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231720304936 |
Similar Items
-
Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity
by: Xiaoqing Zheng, et al.
Published: (2018-04-01) -
Corrigendum to “Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer” [Redox Biol. 34 (2020) 101528]
by: R. González, et al.
Published: (2023-09-01) -
TrxR/Trx inhibitor butaselen ameliorates pulmonary fibrosis by suppressing NF-κB/TGF-β1/Smads signaling
by: Yifan Chen, et al.
Published: (2023-12-01) -
MITF Is Regulated by Redox Signals Controlled by the Selenoprotein Thioredoxin Reductase 1
by: Chelsey D. Kline, et al.
Published: (2022-10-01) -
Disequilibrium in the Thioredoxin Reductase-1/Thioredoxin-1 Redox Couple Is Associated with Increased T-Cell Apoptosis in Children with Autism
by: Samiyah Alshehri, et al.
Published: (2023-02-01)